Xtant Medical Holdings (XTNT) Net Cash Flow (2010 - 2025)

Xtant Medical Holdings (XTNT) has reported Net Cash Flow for 16 consecutive years, with $3.5 million the latest figure, recorded in Q3 2025.

• On a quarterly basis, Net Cash Flow rose 121.8% year-over-year to $3.5 million in Q3 2025; TTM through Sep 2025 was $3.6 million, a 311.82% increase from a year earlier, with the FY2024 full-year figure at $447000.0, up 103.06% from the prior year.
• Net Cash Flow was $3.5 million for Q3 2025 at Xtant Medical Holdings, up from $1.6 million in the prior quarter.
• Over five years, Net Cash Flow peaked at $16.3 million in Q1 2021 and troughed at -$15.1 million in Q1 2023.
• A 5-year average of $440105.3 and a median of -$124000.0 in 2022 frame the typical range for Net Cash Flow.
• Across the five-year window, Net Cash Flow jumped 1379.3% in 2022 and sank 966.17% in 2023, its largest moves.
• Over 5 years, Net Cash Flow stood at -$227000.0 in 2021, then jumped by 1379.3% to $2.9 million in 2022, then sank by 199.97% to -$2.9 million in 2023, then soared by 73.96% to -$756000.0 in 2024, then jumped by 565.61% to $3.5 million in 2025.
• The last three Net Cash Flow figures came in at $3.5 million (Q3 2025), $1.6 million (Q2 2025), and -$784000.0 (Q1 2025), per Business Quant data.